Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

NCT01962181 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

"Attention Deficit Hyperactivity Disorder"

Interventions

DRUG: Ritalin
DRUG: Placebo

Sponsor

Hadassah Medical Organization